How Triterpenes Differ from Polysaccharides in Mechanism

Mushroom Triterpenes and Ganoderic Acids

495 distinct triterpene compounds from 25 Ganoderma species

A 2022 review catalogued 495 distinct triterpenoid compounds described from 25 Ganoderma species in the literature published between 1984 and 2022 — the most comprehensive inventory available.

Galappaththi et al., Biomolecules, 2022

fat-soluble

triterpenes need alcohol extraction, not hot water

Dectin-1 pathway

how beta-glucans signal immune cells

NF-κB suppression

how triterpenes act inside cells on inflammation

Galappaththi et al., Biomolecules, 2022

View as image ↗

If you have ever wondered why dual-extract mushroom products exist, or why hot water reishi tea might not deliver the same effects as an alcohol extract, the answer lies in a fundamental chemical difference between two compound classes that medicinal mushrooms contain: beta-glucans (polysaccharides) and triterpenes.

They dissolve in different things, they reach different parts of the body, they bind to different molecular targets, and they produce different effects. Neither is simply "better." They do different things, and understanding that difference is what the word "dual extraction" actually means.

There is also a popular claim in this space — that reishi triterpenes lower cholesterol by blocking the same enzyme statins block — that does not survive contact with the underlying studies. We work through it below, because getting the mechanism right matters more than making the mushroom sound impressive.

For the broader context on mushroom bioactive compounds, see What Are Beta-Glucans? The Most Important Compound in Medicinal Mushrooms.

Two Completely Different Chemical Classes

Beta-glucans and triterpenes look nothing alike at the molecular level, and that structural difference explains everything else.

Beta-glucans are polysaccharides: long chains of glucose (sugar) units linked in a specific three-dimensional pattern. Think of them as long, branching sugar necklaces. They are water-soluble, which is why hot water extraction captures them. Medicinal mushrooms characteristically produce high-molecular-weight beta-glucans,^[12] and molecules of that size do not slip across cell membranes. Instead, they work by being recognized from outside the cell.

Triterpenes are steroid-like compounds built from 30 carbon atoms arranged in a specific ring structure. The class found in medicinal mushrooms typically uses the lanostane scaffold, a four-ring carbon skeleton related to lanosterol (the precursor from which the body builds cholesterol). Galappaththi and colleagues catalogued 495 distinct triterpenoid compounds described from 25 Ganoderma species across the literature published between 1984 and 2022, noting that triterpenes serve as the primary constituents among more than 600 chemical compounds identified from Ganoderma.^[2] Triterpenes are fat-soluble, dissolving in fats and alcohol rather than water. They are also small: ganoderic acid A, the most abundant of the ganoderic acids, has the formula C₃₀H₄₄O₇,^[19] putting it near 500 daltons — roughly the size of a typical small-molecule drug, and small enough to cross membranes.

Beta-Glucans vs. Triterpenes: Side-by-Side Comparison

This table explains dual extraction: you need hot water to capture the immune-active beta-glucans, and you need alcohol to capture the inflammation-suppressing triterpenes. A product made with only one extraction method necessarily misses half of what the mushroom contains.

Note the lipid row carefully. It is the one place where the popular framing and the evidence diverge, and we deal with it in detail below.

How Beta-Glucans Work: Signaling from the Outside

Beta-glucans from mushrooms are recognized by innate immune cells through a receptor called Dectin-1 and through a family of receptors called Toll-like receptors. Neutrophils, macrophages and dendritic cells all express receptors capable of recognizing beta-glucan in its various forms, and Dectin-1 is the best-characterized of them — the receptor whose translation of recognition into intracellular signaling is understood in the most detail.^[10]

Structural work confirms this is genuine molecular recognition rather than a loose association. Brown and colleagues solved crystal structures of Dectin-1, including one in which a short natural beta-glucan is trapped in the crystal lattice, and showed that the extracellular domain is a C-type lectin-like domain that binds fungal beta-glucans and forms higher-order complexes with them.^[11]

These receptors are pattern-recognition receptors: they evolved to detect highly conserved microbial molecular patterns such as beta-glucan, mannan and lipopolysaccharide. When beta-glucan binds Dectin-1 on a macrophage or dendritic cell, the cell's immunomodulating activity is augmented, and it in turn activates adaptive immune cells — B and T lymphocytes, natural killer cells — by secreting cytokines including IL-4, IL-6 and TNF-α.^[12]

One important nuance: in whole mushroom material, the receptor signal is not always purely glucan-driven. Zhang and colleagues found that the macrophage-activating potential of water-soluble extracts from 13 edible mushrooms was predominantly attributable to TLR2 and TLR4 agonists derived from colonizing bacteria, while the Dectin-1-dependent activity tracked water-insoluble beta-glucans — and that co-stimulation with both produced a synergistic enhancement of cytokine production.^[13] That finding is a useful caution against reading every immune result from a crude mushroom extract as a pure beta-glucan effect.

The defining characteristic of this mechanism remains: beta-glucans work by binding receptors on the outside of cells. The beta-glucan molecule does not itself enter the cell to act. It is a signal. The immune cell does the work in response.

How Triterpenes Work: Acting Inside the Cell

Triterpenes operate differently. Because they are small and fat-soluble, they can cross cell membranes. Once inside, they act on the molecular machinery that controls inflammation.

Dudhgaonkar and colleagues demonstrated this directly in 2009, testing a triterpene extract from Ganoderma lucidum in LPS-stimulated RAW264.7 macrophages.^[1] The extract markedly suppressed secretion of TNF-α, IL-6, nitric oxide and prostaglandin E₂, and down-regulated the enzymes iNOS and COX-2. Critically, they traced the effect to its source: decreased NF-κB DNA-binding activity, suppressed phosphorylation of the p65 subunit, inhibited AP-1 DNA-binding activity, and down-regulated the AP-1 subunit c-Jun. The same extract also inhibited TNF-α and IL-6 production in endotoxemic mice.

This is a genuinely different mode of action from beta-glucan immune stimulation. Beta-glucans activate immune signaling from the cell surface; triterpenes can dampen the transcriptional program driving inflammation from inside. These are complementary effects on different parts of the system, not opposing ones.

A 2025 review by Ren and colleagues in Food Science & Nutrition provides the wider frame: it summarizes the primary bioactive components of G. lucidum — polysaccharides, triterpenoids, peptides and proteins, and sterols — and notes that where the antitumor mechanism was once attributed solely to host immune activation, it is now understood to extend beyond immune modulation to include induction of cell differentiation and inhibition of angiogenesis. The same review is candid that few G. lucidum compounds have been clinically validated as superior to existing therapies.^[4]

That angiogenesis strand has direct experimental support. Stanley and colleagues showed in 2005 that a G. lucidum extract inhibited capillary morphogenesis in human aortic endothelial cells and down-regulated secretion of VEGF and TGF-β1 from PC-3 prostate cancer cells — by inhibiting constitutively active AP-1, through modulation of Erk1/2 and Akt.^[9] Worth noting precisely: this study used a G. lucidum extract and did not isolate the effect to the triterpene fraction. What makes it mechanistically interesting here is the convergence on AP-1 — the same transcription factor Dudhgaonkar's purified triterpenes suppressed.

The Cholesterol Claim: Where the Popular Story Breaks Down

Search for reishi and cholesterol and you will repeatedly find a specific claim: that reishi triterpenes inhibit HMG-CoA reductase, the enzyme statin drugs block, and that this is a mechanism unique to the triterpene class. The structural story is appealing — lanostane triterpenes share their four-ring skeleton with lanosterol, a cholesterol precursor, so a shape-based interaction sounds plausible.

Plausible is not the same as demonstrated. We went to the studies usually cited for this claim, and they do not say it.

So what is true about mushrooms and lipids? Something real, but weaker and less specific than the statin analogy suggests.

Rahman and colleagues did find that a G. lucidum hot water extract at 200 mg/kg body weight lowered plasma total cholesterol, triacylglycerol and LDL cholesterol and raised HDL cholesterol in rats, alongside measurable antioxidant activity.^[6] Li and colleagues found that both Ganoderma triterpenoids and polysaccharides, given to high-fat-diet rabbits for four months, significantly lowered triglycerides, total cholesterol and LDL-C and significantly reduced aortic plaque area — with mechanisms running through NF-κB p65 and LOX-1 in endothelial cells and Notch1/DLL4 in macrophages.^[15] A 2023 systematic review and meta-analysis of 49 animal studies found G. lucidum consumption associated with meaningfully lower TG, TC, LDL-C and VLDL and higher HDL-C.^[16]

The nearest thing to a genuine HMG-CoA reductase finding in the medicinal mushroom literature comes from a different fungus. Peng and colleagues fed Antrodia cinnamomea extract to high-fat-diet mice and found it restored body weight gain, body fat, free fatty acids, triacylglycerol, total cholesterol and the LDL-C/HDL-C ratio, while increasing phosphorylated AMPK and decreasing SREBP, fatty acid synthase and HMG-CoA reductase — the extract being rich in triterpenes, most abundantly antcin K.^[18] Read precisely, that is downregulation of the enzyme through AMPK/SREBP signaling, in Antrodia, in mice — not direct inhibition of the enzyme by a ganoderic acid, which is what the statin analogy implies.

Every one of those results is preclinical. When the same question was asked of human randomized controlled trials, the answer changed.

The 2015 Cochrane review is the most important document here, and the one most often left out of supplement marketing. Klupp and colleagues identified five randomized or controlled trials totalling 398 participants; the three from which data could be analysed compared 1.4 to 3 g/day of G. lucidum against placebo over 12 to 16 weeks, in participants who all had type 2 diabetes. They found no statistically or clinically significant reduction in HbA1c, total cholesterol, LDL cholesterol or BMI, and concluded that the evidence "does not support the use of G lucidum for treatment of cardiovascular risk factors in people with type 2 diabetes mellitus."^[17]

This article is educational and is not medical advice. Nothing here is a recommendation to treat, prevent or manage any medical condition.

Claim Audit · “Reishi Triterpenes Block The Statin Enzyme”

Walking one popular mechanism claim back through its own sources

The claim: reishi triterpenes inhibit HMG-CoA reductase like a statin, a mechanism beta-glucans cannot reproduce. Below is what each study cited in support actually tested and actually measured.

Rahman et al., 2018 — the study the claim is usually hung on[6]Does not show it

Preparation tested: Hot water extract of G. lucidum + five solvent-partitioned fractions, in rats

Outcomes measured: DPPH scavenging, total phenolics, lipid peroxidation, LDL oxidation, catalase/GPx/SOD, and a plasma lipid panel

HMG-CoA reductase was never assayed in this study. The preparation that lowered lipids was the hot water extract — the polysaccharide-rich fraction, not the triterpene fraction. The study cited to prove a triterpene-exclusive enzyme mechanism tested neither the enzyme nor, primarily, the triterpenes.

Peng et al., 2017 — the closest real HMG-CoA finding[18]Adjacent, not equivalent

Preparation tested: Antrodia cinnamomea extract (triterpene-rich, antcin K most abundant), high-fat-diet mice, 10 weeks

Outcomes measured: Body fat, serum lipids, hepatic lipid deposits, pAMPK, SREBP, FAS, AGPAT, HMG-CoA reductase

HMG-CoA reductase genuinely decreased. But this is downregulation of the enzyme through AMPK and SREBP signaling, not a statin-like direct block of the enzyme — and it is Antrodia, not Ganoderma, so it says nothing about ganoderic acids.

Li et al., 2021 — the head-to-head test[15]Does not show it

Preparation tested: G. lucidum triterpenoids AND polysaccharides, high-fat-diet rabbits, 0.3 g/kg/day, 4 months

Outcomes measured: Serum TG, TC, LDL-C; aortic plaque area; NF-κB p65 and LOX-1 in endothelial cells; Notch1/DLL4 in macrophages

Both compound classes lowered lipids and both reduced plaque area. This is the specific comparison the "unique to triterpenes" claim requires, and it comes out against it.

Aref et al., 2023 — pooled animal evidence[16]Supports lipid effect only

Preparation tested: 49 animal studies of G. lucidum on serum lipid profiles

Outcomes measured: TG, TC, LDL-C, HDL-C, VLDL as standardized mean differences

Consistent and sizeable lipid improvements across the animal literature (LDL-C SMD −2.03). Real evidence that Ganoderma affects lipids in animals — and silent on which compound class or which enzyme is responsible.

Klupp et al., 2015 (Cochrane) — the human test[17]Null in humans

Preparation tested: 5 randomized/controlled trials, 398 participants; 3 analysable, 1.4–3 g/day for 12–16 weeks, all in type 2 diabetes

Outcomes measured: HbA1c, total cholesterol, LDL cholesterol, BMI

No statistically or clinically significant reduction in total cholesterol (−0.07 mmol/L; 95% CI −0.57 to 0.42) or LDL-C (0.02 mmol/L; 95% CI −0.41 to 0.45). The authors concluded the evidence does not support using G. lucidum for cardiovascular risk factors in this population.

None of this means reishi does nothing to lipids — the animal evidence is broad and consistent. It means the specific mechanistic story, that a ganoderic acid blocks HMG-CoA reductase the way a statin does and that beta-glucans cannot touch lipids, is not what these studies show. Educational information only; not medical advice, and not a basis for changing prescribed therapy.

Sources: Rahman et al. (2018); Peng et al. (2017); Li et al. (2021); Aref et al. (2023); Klupp et al. (2015)

View as image ↗

Extraction: Why Hot Water Reishi Tea Delivers Minimal Triterpenes

Hot water dissolves polar, water-soluble molecules well. Triterpenes are neither polar nor water-soluble. When you make reishi tea with hot water, you extract primarily the polysaccharides. The ganoderic acids and other triterpenes largely stay in the mushroom material.

Physical structure compounds the problem in some preparations. Wang and colleagues documented in 2017 that the hard, indissolvable sporoderm (outer wall) of Ganoderma lucidum spores hinders the release of the bioactive components inside, and developed a combined chemical and physical method — ultrasonication plus refrigeration — to break it. They evaluated their method specifically by measuring the dissolution of the triterpenoids held within.^[7] In other words: even where triterpenes are present, they can be physically locked away from any solvent until the wall is breached.

For a dual-extract product, the typical process involves a hot water extraction step (capturing polysaccharides) followed by an alcohol extraction step (capturing triterpenes), with the two extracts then combined. This is the standard route to obtaining both compound classes from the same mushroom material.

Products labeled "hot water extract" or "aqueous extract" will deliver beta-glucans but minimal triterpenes. Products labeled "ethanol extract" or "alcohol extract" may deliver triterpenes but reduced polysaccharides. "Dual extract" or "full spectrum extract" indicates both extraction methods were used.

For more on extraction methods and what they deliver, see Double-Extraction Mushroom Tinctures: Why Alcohol + Water Captures More Compounds and Hot Water Extract vs. Dual Extract vs. Raw Powder: Which Delivers More Beta-Glucans?.

Bioavailability: Absorption Depends on the Exact Triterpene

Even when triterpenes are successfully extracted, oral absorption is not guaranteed — and here the commonly repeated version of the evidence is frequently stated backwards.

Wang and colleagues used a Caco-2 human intestinal cell monolayer model to measure bidirectional transport of 14 representative triterpenoids from Antrodia cinnamomea, monitored by a validated LC/MS/MS method.^[8] The result split cleanly along structural lines. The ergostane-type compounds — antcins A, B, C, H and K — were absorbed by passive transcellular diffusion and showed high permeability values (above 2.5 × 10⁻⁵ cm/s). The lanostane-type compounds — dehydroeburicoic acid, eburicoic acid, dehydrosulphurenic acid and 15α-acetyldehydrosulphurenic acid — could "hardly pass through" the monolayer and exhibited poor permeability. Transport behaviour matched the compounds' pharmacokinetics in rats.

That distinction matters directly for reishi, because ganoderic acids are lanostane-type triterpenes. This study was conducted in Antrodia, not Ganoderma, so it does not measure ganoderic acid absorption. But it establishes that "triterpene" is far too coarse a category for predicting absorption, and that the structural subclass reishi's headline compounds belong to was the poorly-absorbed one in this model. The 2026 meta-analysis reaches the same conclusion from a different direction, naming bioavailability as one of the notable absences in the current literature.^[5]

A common practical suggestion is to take fat-soluble extracts with a fat-containing meal. That is reasonable general pharmacology for lipophilic compounds, but it is worth being clear that it was not what these studies tested — Wang's compounds crossed by passive transcellular diffusion in a cell model with no dietary fat involved, and no trial has demonstrated that food timing improves ganoderic acid absorption in humans.

Beta-glucan uptake follows a different route entirely, and it has been mapped in detail. Wang and colleagues (2024) tracked fluorescently labelled lentinan after oral administration and showed it accumulates in Peyer's patches — organized immune tissue in the small intestine — with M cells acting as the main cells transporting it there. Dectin-1 then mediates uptake of the lentinan by mononuclear phagocytes within the Peyer's patches, which proliferate and differentiate in response.^[14] A large polysaccharide does not need to be absorbed into circulation the way a small molecule does; it needs to reach the right immune tissue, and there is a dedicated transport system that takes it there.

Mechanism Map · Two Routes Through The Body

One stops at the membrane. The other goes through it.

The difference between a beta-glucan and a triterpene is not a difference of potency — it is a difference of destination. Follow each from the gut to its molecular target.

Sources: Dudhgaonkar et al. (2009); Wang et al. (2015); Goodridge et al. (2009); Brown et al. (2007); Wang et al. (2024)

View as image ↗

Why Both Compound Classes Matter

The fact that beta-glucans and triterpenes work through different mechanisms is not a reason to prefer one. It is the reason both belong in a comprehensive medicinal mushroom product.

A product delivering only beta-glucans (hot water extract) engages immune signaling through Dectin-1 and Toll-like receptors. A product delivering only triterpenes (alcohol extract) brings the transcriptional anti-inflammatory activity demonstrated by Dudhgaonkar and pooled by the 2026 meta-analysis. A dual extract carries both.

The breadth of the triterpene side is worth appreciating. Wang and colleagues' 2024 review of the previous five years of ganoderic acid research summarized activity across anti-cancer, anti-inflammatory, radiation protection, anti-aging, liver protection, anti-microbial and neuroprotective domains.^[3] Sui and colleagues' 2025 in-depth review of ganoderic acid A specifically found it acting through NF-κB, JAK/STAT, TLR4, Nrf2, PI3K/AKT, mTOR, MAPK and Notch signaling, with network pharmacology and molecular docking analyses converging on MAPK3, TNF, caspase-3, PPARγ and β-catenin as key targets — while also reporting that ganoderic acid A has low bioavailability despite high absorption and elimination rates.^[19]

That last detail is the honest summary of this whole topic. The triterpene mechanism is real, well-characterized at the molecular level, and genuinely distinct from what beta-glucans do. What it does not yet have is the human clinical evidence to match — and no amount of mechanistic elegance substitutes for that.

For a deeper look at the specific ganoderic acids from Reishi, see Ganoderic Acids from Reishi: A Complete Guide. For the broader class of mushroom triterpenes across species, see Mushroom Triterpenes: The Bitter Compounds with Powerful Effects.